Table 1.

Results of univariate log-rank test of the parameters

Parameter	Total no. of patients	No. of patients with event (%)	p-value
Demographic characteristic
Age <50 yr*	38	9 (23.7)	0.183
Female sex*	32	11 (34.4)	0.145
Predisposing condition
Diabetes*	4	3 (75.0)	0.029
Hypertension	10	3 (30.0)	0.823
Clinical manifestation
Prodromal symptom	39	11 (28.2)	0.755
Duration of visual symptom >1 wk	18	6 (33.3)	0.754
Ophthalmologic manifestation
Mean initial BCVA >0.8 logMAR*	15	7 (46.7)	0.099
Anterior chamber cells of 0.5+ to 2+*	21	9 (42.9)	0.074
Keratic precipitates	8	4 (50.0)	0.278
Focal posterior synechiae*	6	5 (83.3)	<0.001
Papillitis	27	9 (33.3)	0.547
SRD height >700 μm in OCT*	16	7 (43.8)	0.083
Treatment method and response
SRD disappearance >1 mon	30	9 (30.0)	0.868
Rebound SRD during steroid tapering*	7	5 (71.4)	0.025
Use of systemic steroid <5 mon	28	9 (32.1)	0.501
Time to initiation of high-dose steroid therapy >7 day from visual symptom development*	27	12 (44.4)	0.019
Use of immunosuppressants	4	2 (50.0)	0.402
Intravitreal triamcinolone acetonide	6	1 (16.7)	0.422

BCVA = best-corrected visual acuity; logMAR = logarithm of the minimum angle of resolution; SRD = serous retinal detachment; OCT = optical coherence tomography.

^*Parameters with p < 0.20 were put into multivariate Cox regression analysis.